다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Omega Therapeutics Inc (OMGA)
Omega Therapeutics Inc (OMGA) 뉴스

OMGA

Omega Therapeutics (OMGA)

Omega Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:OMGA

1 2 3 4 5 6 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	20:00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic Controllers	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2024/05/06	20:00	GlobeNewswire Inc.	Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress	NASDAQ:OMGA	Omega Therapeutics Inc
2024/04/23	20:00	GlobeNewswire Inc.	Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting	NASDAQ:OMGA	Omega Therapeutics Inc
2024/04/09	20:00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control	NASDAQ:OMGA	Omega Therapeutics Inc
2024/03/28	22:15	GlobeNewswire Inc.	Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update	NASDAQ:OMGA	Omega Therapeutics Inc
2024/03/06	21:00	GlobeNewswire Inc.	Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	07:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/02/10	06:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OMGA	Omega Therapeutics Inc
2024/01/06	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2024/01/03	06:05	GlobeNewswire Inc.	Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/12/12	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2023/12/05	06:00	GlobeNewswire Inc.	Omega Therapeutics to Participate in the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/28	09:01	PR Newswire (US)	Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/21	20:00	PR Newswire (US)	Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/21	06:00	GlobeNewswire Inc.	Omega Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/13	21:00	GlobeNewswire Inc.	Omega Therapeutics Showcases Bidirectional and Multiplexed Epigenomic Control of Gene Expression in Preclinical Models of Liver Inflammation and Fibrosis	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/09	21:00	GlobeNewswire Inc.	Omega Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress	NASDAQ:OMGA	Omega Therapeutics Inc
2023/11/08	06:00	GlobeNewswire Inc.	Omega Therapeutics to Participate in The Jefferies London Healthcare Conference	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/31	20:00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data Demonstrating Pre-Transcriptional Modulation of Multiple CXCL Genes by a Single Epigenomic Controller	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/16	20:00	GlobeNewswire Inc.	Omega Therapeutics Presents New Preclinical Data Supporting the Potential of OTX-2101 in Combination Settings for Treatment of NSCLC	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/12	05:00	GlobeNewswire Inc.	Omega Therapeutics Announces Two Poster Presentations on Liver Inflammation and Fibrosis at AASLD’s The Liver Meeting® 2023	NASDAQ:OMGA	Omega Therapeutics Inc
2023/10/05	05:00	GlobeNewswire Inc.	Omega Therapeutics to Present New Preclinical Data on OTX-2101 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics	NASDAQ:OMGA	Omega Therapeutics Inc
2023/09/27	06:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OMGA	Omega Therapeutics Inc
2023/09/26	20:00	GlobeNewswire Inc.	Omega Therapeutics Announces Promising Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial	NASDAQ:OMGA	Omega Therapeutics Inc
2023/09/26	05:00	GlobeNewswire Inc.	Omega Therapeutics to Host Conference Call to Discuss Preliminary Clinical Data for OTX-2002 from Ongoing MYCHELANGELO™ I Trial on September 26	NASDAQ:OMGA	Omega Therapeutics Inc

검색 관련기사 보기:NASDAQ:OMGA

1 2 3 4 5 6 다음 >>

FloatingRate Municipal I...

Burrell Resources

WisdomTree US Efficient ...

Berkshire Hathaway

Dividend Strength Portfo...

Sg Tv Eur3m+0,8 Mg24 Eur

Proof Platform Token

Parkway Corporate

First Trust Exch

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관